5-Amino-1MQ

5-Amino-1MQ 5, 10 & 50 mg (NNMT Inhibitor)

5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase, commonly called NNMT. Unlike a peptide, it acts directly on an enzyme involved in nicotinamide and cellular metabolism.

NNMT transfers a methyl group to nicotinamide and produces 1-methylnicotinamide. Researchers study this pathway because it connects vitamin B3 metabolism with cellular energy balance and methyl-donor availability.

A major area of interest involves adipose-tissue biology. In addition, preclinical models examine NNMT inhibition in relation to fat accumulation, body composition, glucose regulation, insulin signalling, and metabolic flexibility.

Liver and mitochondrial research provide further areas of interest. Scientists investigate how 5-Amino-1MQ-related pathways influence lipid handling, cellular energy use, and communication between metabolically active tissues.

Researchers may compare 5-Amino-1MQ with NAD+, which is closely connected to nicotinamide metabolism, or AOD-9604, another compound studied in metabolic and body-composition models.

For researchers seeking 5-Amino-1MQ in Canada, this compound offers a focused model for studying NNMT activity, adipose tissue, energy metabolism, glucose regulation, and body-composition pathways.

Product Specifications

• Form: Lyophilized powder
• Scientific / alternate name: 5-Amino-1-methylquinolinium
• Vial sizes: 5 mg, 10 mg, 50 mg

For laboratory and research purposes only. Not intended for human or veterinary use, diagnosis, treatment, or consumption.